Therapeutic and diagnostic devices maker, AngioDynamics Inc. (ANGO) recently received 510(k) approval from the U.S. Food and Drug Administration (:FDA) for its BioFlo peripherally inserted central ...
The BioFlo 320, next-generation bioprocess control station, is designed as a universal platform capable of meeting the ever changing needs of all segments of the biotech and pharmaceutical sciences.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results